IPSEF - Ipsen wins FDA approval of rare bone disease drug palovarotene
2023-08-16 17:21:17 ET
More on Ipsen
- Ipsen bone disorder therapy rejected in EU
- Ipsen wins FDA AdCom nod for bone disease therapy
- Mirum falls as FDA expands label for Ipsen’s liver disease therapy
For further details see:
Ipsen wins FDA approval of rare bone disease drug palovarotene